{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T19:45:48Z","timestamp":1772307948860,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1038\/sj.gt.3302914","type":"journal-article","created":{"date-parts":[[2007,2,3]],"date-time":"2007-02-03T03:47:28Z","timestamp":1170474448000},"page":"638-647","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus"],"prefix":"10.1038","volume":"14","author":[{"given":"S","family":"Yang","sequence":"first","affiliation":[]},{"given":"Z S","family":"Guo","sequence":"additional","affiliation":[]},{"given":"M E","family":"O'Malley","sequence":"additional","affiliation":[]},{"given":"X","family":"Yin","sequence":"additional","affiliation":[]},{"given":"H J","family":"Zeh","sequence":"additional","affiliation":[]},{"given":"D L","family":"Bartlett","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2007,2,1]]},"reference":[{"key":"BF3302914_CR1","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1517\/14712598.4.10.1685","volume":"4","author":"T Nakamura","year":"2004","unstructured":"Nakamura T, Russell SJ . Oncolytic measles viruses for cancer therapy. Exp Opin Biol Ther 2004; 4: 1685\u20131692.","journal-title":"Exp Opin Biol Ther"},{"key":"BF3302914_CR2","doi-asserted-by":"publisher","first-page":"7802","DOI":"10.1038\/sj.onc.1209037","volume":"24","author":"M Aghi","year":"2005","unstructured":"Aghi M, Martuza RL . Oncolytic viral therapies \u2013 the clinical experience. Oncogene 2005; 24: 7802\u20137816.","journal-title":"Oncogene"},{"key":"BF3302914_CR3","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1002\/jgm.800","volume":"7","author":"JJ Davis","year":"2005","unstructured":"Davis JJ, Fang B . Oncolytic virotherapy for cancer treatment: challenges and solutions. J Gene Med 2005; 7: 1380\u20131389.","journal-title":"J Gene Med"},{"key":"BF3302914_CR4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/sj.cgt.7700771","volume":"12","author":"B Everts","year":"2005","unstructured":"Everts B, van der Poel HG . Replication-selective oncolytic viruses in the treatment of cancer. Cancer Gene Ther 2005; 12: 141\u2013161.","journal-title":"Cancer Gene Ther"},{"key":"BF3302914_CR5","doi-asserted-by":"publisher","first-page":"7640","DOI":"10.1038\/sj.onc.1209047","volume":"24","author":"CC O'Shea","year":"2005","unstructured":"O'Shea CC . Viruses \u2013 seeking and destroying the tumor program. Oncogene 2005; 24: 7640\u20137655.","journal-title":"Oncogene"},{"key":"BF3302914_CR6","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/nrc1750","volume":"5","author":"KA Parato","year":"2005","unstructured":"Parato KA, Senger D, Forsyth PA, Bell JC . Recent progress in the battle between oncolytic viruses and tumours. Nat Rev Cancer 2005; 5: 965\u2013976.","journal-title":"Nat Rev Cancer"},{"key":"BF3302914_CR7","doi-asserted-by":"publisher","first-page":"429","DOI":"10.2174\/1566523054546215","volume":"5","author":"SH Thorne","year":"2005","unstructured":"Thorne SH, Bartlett DL, Kirn DH . The use of oncolytic vaccinia viruses in the treatment of cancer: a new role for an old ally? Curr Gene Ther 2005; 5: 429\u2013443.","journal-title":"Curr Gene Ther"},{"key":"BF3302914_CR8","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/sj.cgt.7700549","volume":"9","author":"HJ Zeh","year":"2002","unstructured":"Zeh HJ, Bartlett DL . Development of a replication-selective, oncolytic poxvirus for the treatment of human cancers. Cancer Gene Ther 2002; 9: 1001\u20131012.","journal-title":"Cancer Gene Ther"},{"key":"BF3302914_CR9","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1517\/14712598.4.6.901","volume":"4","author":"ZS Guo","year":"2004","unstructured":"Guo ZS, Bartlett DL . Vaccinia as a vector for gene delivery. Expert Opin Biol Ther 2004; 4: 901\u2013917.","journal-title":"Expert Opin Biol Ther"},{"key":"BF3302914_CR10","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ymthe.2004.10.015","volume":"11","author":"Y Shen","year":"2005","unstructured":"Shen Y, Nemunaitis J . Fighting cancer with vaccinia virus: teaching new tricks to an old dog. Mol Ther 2005; 11: 180\u2013195.","journal-title":"Mol Ther"},{"key":"BF3302914_CR11","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1086\/375825","volume":"37","author":"VA Fulginiti","year":"2003","unstructured":"Fulginiti VA, Papier A, Lane JM, Neff JM, Henderson DA . Smallpox vaccination: a review, Part II. Adverse events. Clin Infect Dis 2003; 37: 251\u2013271.","journal-title":"Clin Infect Dis"},{"key":"BF3302914_CR12","first-page":"21","volume":"2","author":"GR Peplinski","year":"1996","unstructured":"Peplinski GR, Tsung K, Casey MJ, Meko JB, Fredrickson TN, Buller RM et al. In vivo murine tumor gene delivery and expression by systemic recombinant vaccinia virus encoding interleukin-1beta. Cancer J Sci Am 1996; 2: 21\u201327.","journal-title":"Cancer J Sci Am"},{"key":"BF3302914_CR13","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/sj.cgt.7700075","volume":"7","author":"M Puhlmann","year":"2000","unstructured":"Puhlmann M, Brown CK, Gnant M, Huang J, Libutti SK, Alexander HR et al. Vaccinia as a vector for tumor directed gene therapy: biodistribution of a thymidine kinase deleted mutant. Cancer Gene Ther 2000; 7: 66\u201373.","journal-title":"Cancer Gene Ther"},{"key":"BF3302914_CR14","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nbt937","volume":"22","author":"YA Yu","year":"2004","unstructured":"Yu YA, Shabahang S, Timiryasova TM, Zhang Q, Beltz R, Gentschev I et al. Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins. Nat Biotechnol 2004; 22: 313\u2013320.","journal-title":"Nat Biotechnol"},{"key":"BF3302914_CR15","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.ymthe.2004.06.158","volume":"10","author":"JA McCart","year":"2004","unstructured":"McCart JA, Mehta N, Scollard D, Reilly RM, Carrasquillo JA, Tang N et al. Oncolytic vaccinia virus expressing the human somatostatin receptor SSTR2: molecular imaging after systemic delivery using 111In-pentetreotide. Mol Ther 2004; 10: 553\u2013561.","journal-title":"Mol Ther"},{"key":"BF3302914_CR16","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrmicro1099","volume":"3","author":"G McFadden","year":"2005","unstructured":"McFadden G . Poxvirus tropism. Nature Rev Microbiol 2005; 3: 201\u2013213.","journal-title":"Nature Rev Microbiol"},{"key":"BF3302914_CR17","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1089\/hum.2005.16.435","volume":"16","author":"E Chang","year":"2005","unstructured":"Chang E, Chalikonda S, Friedl J, Xu H, Phan GQ, Marincola FM et al. Targeting vaccinia to solid tumors with local hyperthermia. Hum Gene Ther 2005; 16: 435\u2013444.","journal-title":"Hum Gene Ther"},{"key":"BF3302914_CR18","first-page":"8751","volume":"61","author":"JA McCart","year":"2001","unstructured":"McCart JA, Ward JM, Lee J, Hu Y, Alexander HR, Libutti SK et al. Systemic cancer therapy with a tumor-selective vaccinia virus mutant lacking thymidine kinase and vaccinia growth factor genes. Cancer Res 2001; 61: 8751\u20138757.","journal-title":"Cancer Res"},{"key":"BF3302914_CR19","first-page":"3396","volume":"59","author":"MFX Gnant","year":"1999","unstructured":"Gnant MFX, Puhlmann M, Alexander HR, Bartlett DL . Systemic administration of a recombinant vaccinia virus expressing the cytosine deaminase gene and subsequent treatment with 5-fluorocytosine leads to tumor specific gene expression and prolongation of survival in mice. Cancer Res 1999; 59: 3396\u20133404.","journal-title":"Cancer Res"},{"key":"BF3302914_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1089\/hum.2006.17.31","volume":"17","author":"AM Naik","year":"2006","unstructured":"Naik AM, Chalikonda S, McCart JA, Xu H, Guo ZS, Langham G et al. Intravenous and isolated limb perfusion delivery of wild type and a tumor-selective replicating mutant vaccinia virus in nonhuman primates. Hum Gene Ther 2006; 17: 31\u201345.","journal-title":"Hum Gene Ther"},{"key":"BF3302914_CR21","doi-asserted-by":"publisher","first-page":"6069","DOI":"10.1038\/sj.onc.1208734","volume":"24","author":"TC Liu","year":"2005","unstructured":"Liu TC, Kirn D . Viruses with deletions in antiapoptotic genes as potential oncolytic agents. Oncogene 2005; 24: 6069\u20136079.","journal-title":"Oncogene"},{"key":"BF3302914_CR22","doi-asserted-by":"publisher","first-page":"33293","DOI":"10.1074\/jbc.R100016200","volume":"276","author":"GA Silverman","year":"2001","unstructured":"Silverman GA, Bird PI, Carrell RW, Church FC, Coughlin PB, Gettins PGW et al. The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. J Biol Chem 2001; 276: 33293\u201333296.","journal-title":"J Biol Chem"},{"key":"BF3302914_CR23","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1006\/viro.1994.1347","volume":"202","author":"AN Ali","year":"1994","unstructured":"Ali AN, Turner PC, Brooks MA, Moyer RW . The Spi-1 gene of rabbitpox virus determines host-range and is required for hemorrhagic pock formation. Virology 1994; 202: 305\u2013314.","journal-title":"Virology"},{"key":"BF3302914_CR24","doi-asserted-by":"crossref","first-page":"7688","DOI":"10.1128\/jvi.69.12.7688-7698.1995","volume":"69","author":"MA Brooks","year":"1995","unstructured":"Brooks MA, Ali AN, Turner PC, Moyer RW . A rabbitpox virus serpin gene controls host range by inhibiting apoptosis in restrictive cells. J Virol 1995; 69: 7688\u20137698.","journal-title":"J Virol"},{"key":"BF3302914_CR25","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S0042-6822(95)80028-X","volume":"206","author":"S Kettle","year":"1995","unstructured":"Kettle S, Blake NW, Law KM, Smith GL . Vaccinia virus serpins B13R (SPI-2) and B22R (SPI-1) encode M(r) 38.5 and 40\u2009K, intracellular polypeptides that do not affect virus virulence in a murine intranasal model. Virology 1995; 206: 136\u2013147.","journal-title":"Virology"},{"key":"BF3302914_CR26","doi-asserted-by":"publisher","first-page":"9108","DOI":"10.1073\/pnas.93.17.9108","volume":"93","author":"JL Macen","year":"1996","unstructured":"Macen JL, Garner RS, Musy PY, Brooks MA, Turner PC, Moyer RW et al. Differential inhibition of the Fas- and granule-mediated cytolysis pathways by the orthopoxvirus cytokine response modifier A\/SPI-2 and SPI-1 protein. Proc Natl Acad Sci USA 1996; 93: 9108\u20139113.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302914_CR27","doi-asserted-by":"publisher","first-page":"9991","DOI":"10.1158\/0008-5472.CAN-05-1630","volume":"65","author":"ZS Guo","year":"2005","unstructured":"Guo ZS, Naik A, O'Malley ME, Popovic P, DeMarco R, Hu Y et al. The enhanced tumor selectivity of an oncolytic vaccinia lacking the host range and anti-apoptosis genes SPI-1 and SPI-2. Cancer Res 2005; 65: 9991\u20139998.","journal-title":"Cancer Res"},{"key":"BF3302914_CR28","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nrc776","volume":"2","author":"FH Igney","year":"2002","unstructured":"Igney FH, Krammer PH . Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer 2002; 2: 277\u2013288.","journal-title":"Nat Rev Cancer"},{"key":"BF3302914_CR29","doi-asserted-by":"publisher","first-page":"8804","DOI":"10.1073\/pnas.161011798","volume":"98","author":"S Taneja","year":"2001","unstructured":"Taneja S, MacGregor J, Markus S, Ha S, Mohr I . Enhanced antitumor efficacy of a herpes simplex virus mutant isolated by genetic selection in cancer cells. Proc Natl Acad Sci USA 2001; 98: 8804\u20138808.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302914_CR30","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/jnci\/djj161","volume":"98","author":"H Ito","year":"2006","unstructured":"Ito H, Aoki H, Kuhnel P, Kondo Y, Kubicka S, Wirth T et al. Autophagic cell death of malignant glioma cells induced by a conditionally replicating adenovirus. J Natl Cancer Inst 2006; 98: 625\u2013636.","journal-title":"J Natl Cancer Inst"},{"key":"BF3302914_CR31","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1126\/science.1096645","volume":"304","author":"L Yu","year":"2004","unstructured":"Yu L, Alva A, Su H, Dutt P, Freundt E, Welsh S et al. Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 2004; 304: 1500\u20131502.","journal-title":"Science"},{"key":"BF3302914_CR32","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1517\/14712598.4.4.575","volume":"4","author":"S Essajee","year":"2004","unstructured":"Essajee S, Kaufman HL . Poxvirus vaccines for cancer and HIV therapy. Expert Opin Biol Ther 2004; 4: 575\u2013588.","journal-title":"Expert Opin Biol Ther"},{"key":"BF3302914_CR33","first-page":"549","volume":"7","author":"Y Woo","year":"2006","unstructured":"Woo Y, Adusumilli PS, Fong Y . Advances in oncolytic viral therapy. Curr Opin Investig Drugs 2006; 7: 549\u2013559.","journal-title":"Curr Opin Investig Drugs"},{"key":"BF3302914_CR34","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1089\/10430349950018724","volume":"10","author":"M Puhlmann","year":"1999","unstructured":"Puhlmann M, Gnant M, Brown CK, Alexander HR, Bartlett DL . Thymidine kinase deleted vaccinia virus expressing purine nucleoside phosphorylase as a vector for tumor directed gene therapy. Hum Gene Ther 1999; 10: 649\u2013657.","journal-title":"Hum Gene Ther"},{"key":"BF3302914_CR35","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/sj.gt.3301237","volume":"7","author":"JA McCart","year":"2000","unstructured":"McCart JA, Puhlmann M, Lee J, Hu Y, Libutti SK, Alexander HR et al. Complex interactions between the replicating oncolytic effect and the enzyme\/prodrug effect of vaccinia-mediated tumor regression. Gene Ther 2000; 7: 1217\u20131223.","journal-title":"Gene Ther"},{"key":"BF3302914_CR36","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.1016\/S1471-4914(02)02318-3","volume":"8","author":"D Kirn","year":"2002","unstructured":"Kirn D, Niculescu-Duvaz I, Hallden G, Springer CJ . The emerging fields of suicide gene therapy and virotherapy. Trends Mol Med 2002; 8: S68\u2013S73.","journal-title":"Trends Mol Med"},{"key":"BF3302914_CR37","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/sj.cgt.7700538","volume":"9","author":"MJ Mastrangelo","year":"2002","unstructured":"Mastrangelo MJ, Lattime EC . Virotherapy clinical trials for regional disease: in situ immune modulation using recombinant poxvirus vectors. Cancer Gene Ther 2002; 9: 1013\u20131021.","journal-title":"Cancer Gene Ther"},{"key":"BF3302914_CR38","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1073\/pnas.0409846102","volume":"102","author":"FA Legrand","year":"2005","unstructured":"Legrand FA, Verardi PH, Chan KS, Peng Y, Jones LA, Yilma TD . Vaccinia viruses with a serpin gene deletion and expressing IFN-gamma induce potent immune responses without detectable replication in vivo. Proc Natl Acad Sci USA 2005; 102: 2940\u20132945.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302914_CR39","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ymthe.2006.05.008","volume":"14","author":"JH Kim","year":"2006","unstructured":"Kim JH, Oh JY, Park BH, Lee DE, Kim JS, Park HE et al. Systemic armed oncolytic and immunologic therapy for cancer with JX-594, a targeted poxvirus expressing GM-CSF. Mol Ther 2006; 14: 361\u2013370.","journal-title":"Mol Ther"},{"key":"BF3302914_CR40","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1158\/0008-5472.CAN-05-3020","volume":"66","author":"ZS Guo","year":"2006","unstructured":"Guo ZS, Hong JA, Irvine KR, Chen GA, Spiess PJ, Liu Y et al. De novo induction of a cancer\/testis antigen by 5-aza-2\u2032-deoxycytidine augments adoptive immunotherapy in a murine tumor model. Cancer Res 2006; 66: 1105\u20131113.","journal-title":"Cancer Res"},{"key":"BF3302914_CR41","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1126\/science.1121411","volume":"311","author":"SH Thorne","year":"2006","unstructured":"Thorne SH, Negrin RS, Contag CH . Synergistic antitumor effects of immune cell-viral biotherapy. Science 2006; 311: 1780\u20131784.","journal-title":"Science"},{"key":"BF3302914_CR42","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1093\/carcin\/21.4.585","volume":"21","author":"KF Roby","year":"2000","unstructured":"Roby KF, Taylor CC, Sweetwood JP, Cheng Y, Pace JL, Tawfik O et al. Development of a syngeneic mouse model for events related to ovarian cancer. Carcinogenesis 2000; 21: 585\u2013591.","journal-title":"Carcinogenesis"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/3302914.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3302914","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3302914.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T17:45:44Z","timestamp":1684863944000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/3302914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2,1]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["BF3302914"],"URL":"https:\/\/doi.org\/10.1038\/sj.gt.3302914","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2,1]]},"assertion":[{"value":"23 August 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2006","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2006","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}